Rxsight

About Rxsight

RxSight operates in the medical device industry, specializing in advanced vision correction solutions. The company's core product is the Light Adjustable Lens (LAL), a unique intraocular lens that can be adjusted post-implantation to achieve optimal vision outcomes. This technology primarily serves patients undergoing cataract surgery, offering them the ability to fine-tune their vision after the procedure, which is a significant advancement over traditional monofocal lenses. RxSight's business model involves the sale of these specialized lenses and the associated Light Delivery Device (LDD) to ophthalmologists and eye care clinics. Revenue is generated through the direct sale of these products and potentially through follow-up adjustments and services. The company targets a niche market of patients with cataracts and corneal astigmatism, aiming to improve their quality of life by providing superior visual outcomes.